J D Elliott - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J D Elliott

Showing results (41-50 of 45) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 45 results.

The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996

Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonistE H Ohlstein, P Nambi, A Lago, et al.

Journal of Physics. Condensed Matter : an Institute of Physics Journal|January 26, 2016

The potential of imogolite nanotubes as (co-)photocatalysts: a linear-scaling density functional theory studyE Poli, J D Elliott, L E Ratcliff, et al.

Journal of Medicinal Chemistry|May 27, 1994

1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonistsJ D Elliott, M A Lago, R D Cousins, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994

Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptorsP Nambi, N Elshourbagy, H L Wu, et al.

Journal of Medicinal Chemistry|March 18, 1994

Conformationally constrained peptides and semipeptides derived from RGD as potent inhibitors of the platelet fibrinogen receptor and platelet aggregationF E Ali, D B Bennett, R R Calvo, et al.

Pageof 5

Search research articles

Showing results (41-50 of 45) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 45 results.

The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996

Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonistE H Ohlstein, P Nambi, A Lago, et al.

Journal of Physics. Condensed Matter : an Institute of Physics Journal|January 26, 2016

The potential of imogolite nanotubes as (co-)photocatalysts: a linear-scaling density functional theory studyE Poli, J D Elliott, L E Ratcliff, et al.

Journal of Medicinal Chemistry|May 27, 1994

1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonistsJ D Elliott, M A Lago, R D Cousins, et al.

The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994

Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptorsP Nambi, N Elshourbagy, H L Wu, et al.

Journal of Medicinal Chemistry|March 18, 1994

Conformationally constrained peptides and semipeptides derived from RGD as potent inhibitors of the platelet fibrinogen receptor and platelet aggregationF E Ali, D B Bennett, R R Calvo, et al.

Pageof 5